P8IP
TXG icon

Pier 88 Investment Partners’s 10x Genomics TXG Stock Holding History

Pier 88 Investment Partners’s Portfolio TXG Stock Details TXG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-20
Closed -$232 – 128
2025
Q2 		$232 Sell
20
-200
-91% -$1.82K ﹤0.01% 105
2025
Q1 		$1.92K Sell
220
-10,260
-98% -$129K ﹤0.01% 101
2024
Q4 		$150K Sell
10,480
-2,300
-18% -$36.3K 0.03% 91
2024
Q3 		$289K Sell
12,780
-220
-2% -$4.55K 0.06% 84
2024
Q2 		$253K Buy
13,000
+5,900
+83% +$154K 0.06% 90
2024
Q1 		$266K Buy
7,100
+2,410
+51% +$106K 0.07% 83
2023
Q4 		$262K Sell
4,690
-5,000
-52% -$218K 0.07% 79
2023
Q3 		$400K Hold
9,690
– – 0.1% 80
2023
Q2 		$541K Buy
9,690
+5,500
+131% +$298K 0.13% 74
2023
Q1 		$234K Hold
4,190
– – 0.06% 80
2022
Q4 		$153K Buy
4,190
+1,680
+67% +$54.9K 0.04% 81
2022
Q3 		$71K Sell
2,510
-3,590
-59% -$137K 0.02% 95
2022
Q2 		$276K Buy
6,100
+3,760
+161% +$195K 0.07% 88
2022
Q1 		$178K Sell
2,340
-2,590
-53% -$227K 0.06% 80
2021
Q4 		$734K Buy
4,930
+3,900
+379% +$597K 0.16% 79
2021
Q3 		$150K Sell
1,030
-3,875
-79% -$665K 0.05% 107
2021
Q2 		$961K Sell
4,905
-1,240
-20% -$224K 0.28% 81
2021
Q1 		$1.11M Sell
6,145
-590
-9% -$102K 0.38% 58
2020
Q4 		$954K Sell
6,735
-995
-13% -$144K 0.31% 69
2020
Q3 		$964K Buy
7,730
+1,015
+15% +$107K 0.29% 72
2020
Q2 		$600K Buy
+6,715
New +$523K 0.17% 92

Other funds holding TXG

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $154B AUM 29.96% 1-Year Est. Return
NAMA
Nikko Asset Management Americas New York $7.07B AUM 50.91% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
QCM
Quantinno Capital Management New York $59.9B AUM 28.07% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Pier 88 Investment Partners's TXG Position: Q3 2025 in Review

Pier 88 Investment Partners sold out of 10x Genomics (TXG) in Q3 2025, closing a stake of 20 shares — an estimated $232 sold.

Pier 88 Investment Partners first reported a position in TXG in Q2 2020 and held it in 21 quarters. The position peaked at $1.11M in Q1 2021. 317 funds tracked by Wall St. Rank hold TXG as of Q3 2025.

  • Pier 88 Investment Partners reported no remaining 10x Genomics position as of Q3 2025 after selling out during the quarter.
  • Pier 88 Investment Partners sold 20 10x Genomics shares in Q3 2025, an estimated $232.
  • Pier 88 Investment Partners first reported a position in 10x Genomics in Q2 2020 and held it in 21 quarters.
  • Pier 88 Investment Partners's 10x Genomics position peaked at $1.11M in Q1 2021.
  • 317 funds tracked by Wall St. Rank held 10x Genomics as of Q3 2025.

Based on Pier 88 Investment Partners's 13F filing for Q3 2025, filed 31 Oct 2025.